Skip to main content
Clinical Trials/NCT01283126
NCT01283126
Completed
Not Applicable

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Joslin Diabetes Center1 site in 1 country20 target enrollmentJanuary 2011
ConditionsHypoglycemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypoglycemia
Sponsor
Joslin Diabetes Center
Enrollment
20
Locations
1
Primary Endpoint
cognitive function correlation to blood or interstitial glucose
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to find out the effects of hypoglycemia on cognition in healthy individuals and how well changes in (interstitial) tissue glucose levels correlate with changes in cognitive function as compared to blood glucose levels.

Detailed Description

Subjects will undergo hypoglycemic clamps during which interstitial glucose will be measured and cognitive function will be assessed.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
October 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • non obese (BMI \<30), ages 18-50

Exclusion Criteria

  • renal or hepatic failure
  • cancer or lymphoma
  • malabsorption or malnourishment
  • hypercortisolism
  • alcoholism or drug abuse
  • eating disorder or depression
  • coronary artery disease
  • Arrhythmias
  • hypertension
  • on medications known to affect the blood glucose to be measured such as

Outcomes

Primary Outcomes

cognitive function correlation to blood or interstitial glucose

Time Frame: 1 year

This investigator initiated study will evaluate cognitive function at the onset, during and following recovery from hypoglycemia and will determine if cognitive function correlates better with blood or interstitial glucose concentrations.

Study Sites (1)

Loading locations...

Similar Trials